On March 26, 2025 ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, reported to have invited current and prospective investors to its Investor Day program to be held on Tuesday, April 15, 2025, at 10:00 am PDT (Press release, ImmunityBio, MAR 26, 2025, View Source [SID1234651460]). The program will include an in-depth update on the company’s business operations and recent R&D advancements. Key timelines for catalysts of product candidates will be presented, along with a discussion of ongoing clinical trials.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"ImmunityBio commenced 2025 with notable scientific and business milestones," said Richard Adcock, President and CEO of ImmunityBio. "With a promising future ahead, we are eager to engage with our investors and share the reasons we’re optimistic and excited about the company’s growth trajectory."
The program will feature a presentation by ImmunityBio Founder, Executive Chairman and Global Chief Scientific and Medical Officer, Dr. Patrick Soon-Shiong, outlining the fundamental science underpinning the company’s technology platforms. This technology harnesses the immune system to deliver long-term disease protection and prevention.
"We have been relentlessly pursuing an innovative scientific approach to immunology that we believe will revolutionize cancer care," remarked Dr. Patrick Soon-Shiong. "Not only has this approach produced ANKTIVA, our initial therapeutic, but the future appears bright as we continue our pursuit of developing a Therapeutic BioShield across multiple tumor types."
This limited space event will be held in person at the company’s facilities in El Segundo, California. A tour of select manufacturing facilities will be provided, showcasing the company’s efficient and scalable production capabilities.
Individuals wishing to attend in person must contact [email protected]. The event will also be live-streamed.
The live stream can be found at
View Source;tp_key=40dc7065b5
Participant Listening (Listen Only)
1-844-539-3703 or 1-412-652-1273